1. Anfinsen CB. Principles that govern the folding of protein chains. Science 1973;181:223–230.

2. Bunin BA, Ellman JA. A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives. J Am Chem Soc 1992;114:10997–10998.

3. Dahl SG, Edvardsen Ø, Sylte I. Molecular dynamics of dopamine at the D2 receptor. Proc Natl Acad Sci USA 1991;88:8111–8115.

4. DeLorey TM, Olsen RW. g-Aminobutyric acid receptor structure and function. J Biol Chem 1992;267:16747–16751.

5. DeVos AM, Tong L, Milburn MV, Matias PM, Jancarik J, Noguchi S, Nishimura S, Miura K, Ohtsuka E, Kim S-H. Three dimensional structure of an oncogene protein. Catalytic domain of human C-H-ras p21. Science 1988;239:888–893.

6. Deisenhofer J, Epp O, Miki K, Huber R, Michel H. Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3 Å resolution. Nature 1985;318:618–624.

7. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Mumford RA, Slater EE, Sigal IS, Caron MG, Lefkowitz RJ, Strader CD. Cloning of the gene and cDNA for mammalian b-adrenergic receptor and homology with rhodopsin. Nature 1986;321:75–79.

8. Dixon RA, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, Strader CD. Ligand binding to the b-adrenergic receptor involves its rhodopsin-like core. Nature 1987;326:73–77.

9. Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD. Structural features required for ligand binding to the b-adrenergic receptor. EMBO J 1987;6:3269–3275.

10. Edvardsen Ø, Style I, Dahl SG. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor. Mol Brain Res 1992;14:166–178.

11. Erickson JW, Fesik SW. Macromolecular x-ray crystallography and NMR as tools for structure-based drug design. Annu Rep Med Chem 1992;27:271–287.

12. Evans CJ, Keith, DE, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opoid receptor by functional expression. Science 1992;258:1952–1955.

13. Fong YM, Cascieri MA, Yu H, Bansai A, Swain C, Strader C. Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature 1993;362:350–353.

14. Freissmuth M, Selzer E, Marullo S, Shutz W, Strosberg D. Expression of two human b-adrenergic receptors in E. coli a: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci USA 1991;88:8548–8552.

15. Ffrench-Constant R, Rocheleau T, Steichen J, Chalmers A. Molecular basis of resistance to picrotoxinin and cyclodiene insecticides in a Drosophila GABA receptor. Soc Neurosci Abstr 1993;19:852.

16. Frohman M, Dush M, Martin G. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 1988;85:8998–9002.

17. Gether U, Yokota Y, Edmonds-Alt X, Brelaiere J, Lowe J, Snider R, Nakanishi S, Schwartz T. Two non peptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Proc Natl Acad Sci USA 1993;90:6194–6198.

18. Green W, Claudio T. Acetylcholine receptor assembly, subunit folding and oligomerization occur sequentially. Cell 1993;74:57–69.

19. Galzi J, Devillers-Thiery A, Hussy N, Bertrand S, Changoux J, Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature 1992;359:500–504.

20. Hartnett C, Yu J, Brown M, Gerber K, Primus R, Ramabhadran R, Gallager D. Effect of subunit composition on GABA/benzodiazepine receptor binding characteristics in a baculovirus expression system. Soc Neurosci Abstr 1993;19(1):477.

21. Henderson R, Unwin PNT. Three-dimensional model of purple membrane obtained by electron microscopy. Nature 1975;257:28–32.

22. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J Mol Biol 1990; 213:899–929.

23. Hingorani VN, Ho Y-K. A structural model for the a-subunit of transducin. Implications of its role as a molecular switch in the visual signal transduction mechanism. FEBS Lett 1987;220:15–22.

24. Ho BY, Karschin A, Branchek T, Davidson N, Lester HA. The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1A receptor: a site-directed mutation study. FEBS Lett 1992;312:259–262.

25. Holbrook SR, Kim S-H. Molecular model of the G protein or a subunit based on the crystal structure of the HRAS protein. Proc Natl Acad Sci USA 1989;86:1751–1755.

26. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78:3824–3828.

27. Howlett A, Bidaut-Russel M, Devane W, Melvin L, Johnson M, Herkenham M. The cannabinoid receptor: biochemical, anatonical and behavioral characterization Trends Neurosci 1990;13:420–423.

28. Jähnig F, Edholm O. Modeling of the structure of bacteriorhodopsin. A molecular dynamics study. J Mol Biol 1992;226:837–850.

29. Jan L, Jan Y. Voltage sensitive ion channels. Cell 1989;56:13–25.

30. Jurnak F. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. Science 1985;230:32–36.

31. Karnik SS, Khorana HG. Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187. J Biol Chem 1990;265:17520–17524.

32. Kaziro Y, Itoh H, Kozasa T, Nakafuku M, Satoh T. Structure and function of signal-transducing GTP-binding proteins. Annu Rev Biochem 1991;60:349–400.

33. Kemp JA, Lesson PD. The glycine site of the NMDA receptor-five years on. Trends Pharmacol Sci 1993;14:20–25.

34. Khorana HG. Two light-transducing membrane proteins: Bacteriorhodopsin and the mammalian rhodopsin. Proc Natl Acad Sci USA 1993;90:1166–1171.

35. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157:105–132.

36. Laborit H. Sur l'utilization de certain agents pharmacodynamiques à action neuro-vegetative en periode per-et postoperatoire. Acta Chir Belg 1949;48:485–492.

37. Lubbert H, Hoffman B, Snutch T, vanDyke T, Levine A, Hartig, P, Lester H, Davidson N. cDNA cloning of a serotonin 1c receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Nat Acad Sci USA 1987;87:928–932.

38. Luckow V. Protein production and processing from baculovirus expression vectors. In: Granados RR, Hammer DA, Wood HA, Shuler M, eds. Insect cell cultures: biopesticide and protein production. New York: Wiley, 1993.

39. Maloney Huss K, Lybrand TP. Three-dimensional structure for the b2 adrenergic receptor protein based on computer modeling studies. J Mol Biol 1992;225:859–871.

40. Mansour A, Meng F, Meador-Woodruff JH, Taylor LP, Civelli O, Akil H. Site directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol Mol Pharmacol 1992;227:205–214.

41. Maricq A, Peterson A, Brake A, Myers R, Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991;254:432–437.

42. Masters SB, Stroud RM, Bourne HR. Family of G protein a chains: amphipathic analysis and predicted structure of functional domains. Protein Eng 1986;1:47–54.

43. Mills A, Duggan M. Orphan seven transmembrane domain receptors: reversing pharmacology. Trends Pharmacol Sci 1993;14:394–396.

44. Moos WH, Green G, Pavia MR. Recent advances in the generation of molecular diversity. Annu Rep Med Chem 1993;28:315–324.

45. Noda M, Takahashi H, Tanabe T, Toyosato M, Furutani Y, Hirose T, Asai M, Inayama S, Miyata T, Numa S. Primary structure of a-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature 1982;299:793–797.

46. Olney J, Labruyere J, Price M. Phencyclidine, dizocilpine, and cerebrocortical neurons. Science 1990;247:221.

47. Pert C, Snyder S. Opiate receptor: demonstration in nervous system. Science 1973;179:1011–1014.

48. Pollock NJ, Manelli AM, Hutchins CW, Steffey ME, MacKenzie RG, Frail DE. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J Biol Chem 1992;267:17780–17786.

49. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992;11:1–20.

50. Prittchett D, Luddens B, Seeburg P. Type I and II GABAa benzodiazepine receptors produced by transfected cells. Science 1989; 245:1389–1392.

51. Randall LO. Discovery of benzodiazepines. In: Usdin E, Skolnick P, Tallman J, Greenblatt D, Paul S, eds. Pharmacology of benzodiazepines. London: Macmillan, 1982;15–21.

52. Richardson JS, Thomas KA, Rubin BH, Richardson DC. Crystal structure of bovine Cu, Zn superoxide dismutase at 3 Angstrøms resolution, chain tracing and metal ligands. Proc Natl Acad Sci USA 1975;72:1349–1353.

53. Rogawski M, Porter R. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharm Rev 1990;42:223–286.

54. Savarese TM, Fraser CM. In vitro mutagenesis and the search for structure–function relationships among G protein-coupled receptors. Biochem J 1992;283:1–19.

55. Schertler GFX, Villa C, Henderson R. Projection structure of rhodopsin. Nature 1993;362:770–772.

56. Seeburg, P. The molecular biology of the mammalian glutamate receptor channels. Trends Neurosci 1993;16:359–365.

57. Smith G, Olsen R. Identification of a 3H muscimol photoaffinity substrate in GABAa receptor alpha subunit. Soc Neurosci Abstr 1993;19:476.

58. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RA. Identification of residues required for ligand binding to the b-adrenergic receptor. Proc Natl Acad Sci USA 1987;84:4384–4388.

59. Strader CD, Candelore MR, Hill WS, Sigal IS, Dixon RAF. Identification of two serine residues involved in agonist activation of the b-adrenergic receptor. J Biol Chem 1989;264:13572–13578.

60. Sylte I, Edvardsen Ø, Dahl SG. Molecular dynamics of the 5-HT1a receptor and ligands. Protein Eng 1993;6:691–700.

61. Tallman, J, Gallager, D. The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci 1985;8:21–44.

62. Tota MR, Strader CD. Characterization of the binding domain of the b-adrenergic receptor with the fluorescent antagonist carazolol. J Biol Chem 1990;265:16891–16897.

63. Unwin N. The nicotinic acetylcholine receptor at 9 Å resolution. J Membr Biol 1993;229:1101–1124.

64. Van Tol H, Bunzow J, Guan H, Sunahara R, Seeman P, Niznik H, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350:610–614.

65. Venter JC, Fraser CM, Kerlavage AR, Buck MA. Molecular biology of adrenergic and muscarinic cholinergic receptors. A perspective. Biochem Pharmacol 1989;38:1197–1208.

66. Wade RC, Luty BA, Demchuk E, Madura JD, Davis ME, Briggs JM, McCammon JA. Simulation of enzyme–substrate encounter with gated active sites. Struct Biol 1994;1:65–69.

67. Young D, Waitches G, Birchmeier C. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 1986;45:711–716.

Back to Chapter